WallStreetZen

NASDAQ: ANGO
Angiodynamics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANGO

Based on 2 analysts offering 12 month price targets for Angiodynamics Inc.
Min Forecast
$32.00+25.54%
Avg Forecast
$34.50+35.35%
Max Forecast
$37.00+45.15%

Should I buy or sell ANGO stock?

Based on 3 analysts offering ratings for Angiodynamics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ANGO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Canaccord Genuity
Bottom 2%
2
Strong BuyUpgrades$37.00+45.15%2021-10-15
Oppenheimer
Top 41%
60
HoldInitiates Coverage OnN/AN/A2021-08-20
Anonymous
Canaccord Genuity
HoldMaintains$28.00+9.85%2021-07-14
Raymond James
Top 13%
88
Strong BuyMaintains$32.00+25.54%2021-07-09

1 of 1

Forecast return on equity

Is ANGO forecast to generate an efficient return?
Company
N/A
Industry
11.59%
Market
37.5%

Forecast return on assets

Is ANGO forecast to generate an efficient return on assets?
Company
N/A
Industry
6.62%

ANGO earnings per share forecast

What is ANGO's earnings per share in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$0.01-101.14%
Avg 2 year Forecast
$0.17-119.32%

ANGO revenue forecast

What is ANGO's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$313.3M+5.22%
Avg 2 year Forecast
$337.0M+13.18%
Avg 3 year Forecast
$366.3M+23.02%
ANGO's revenue is forecast to grow at a rate of 6.95% per year, which is not exceptional
Forecast

ANGO revenue growth forecast

How is ANGO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
6.95%
Industry
6.82%
Market
10.08%
ANGO's revenues are forecast to grow faster (6.95% per year) than the US Medical Instruments & Supplies industry average (6.82%)
Forecast
ANGO's revenues are forecast to grow slower (6.95% per year) than the US market average (10.08%)
Forecast

Angiodynamics Stock Forecast FAQ

Is Angiodynamics Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ANGO) stock is to Strong Buy ANGO stock.

Out of 3 analysts, 2 (66.67%) are recommending ANGO as a Strong Buy, 0 (0%) are recommending ANGO as a Buy, 1 (33.33%) are recommending ANGO as a Hold, 0 (0%) are recommending ANGO as a Sell, and 0 (0%) are recommending ANGO as a Strong Sell.

What is ANGO's earnings growth forecast for 2022-2023?

(NASDAQ: ANGO) Angiodynamics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 26.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Angiodynamics's earnings in 2021 is -$34,252,000.On average, 3 Wall Street analysts forecast ANGO's earnings for 2022 to be $386,504, with the lowest ANGO earnings forecast at $386,504, and the highest ANGO earnings forecast at $773,009.

In 2023, ANGO is forecast to generate $6,570,574 in earnings, with the lowest earnings forecast at $5,024,556 and the highest earnings forecast at $8,503,095.

What is ANGO's revenue growth forecast for 2022-2024?

(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of 6.95% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Angiodynamics's revenue in 2021 is $297,765,000.On average, 3 Wall Street analysts forecast ANGO's revenue for 2022 to be $12,109,567,477, with the lowest ANGO revenue forecast at $12,052,364,834, and the highest ANGO revenue forecast at $12,163,291,580. On average, 3 Wall Street analysts forecast ANGO's revenue for 2023 to be $13,026,085,218, with the lowest ANGO revenue forecast at $12,892,625,269, and the highest ANGO revenue forecast at $13,102,497,126.

In 2024, ANGO is forecast to generate $14,157,653,974 in revenue, with the lowest revenue forecast at $14,157,653,974 and the highest revenue forecast at $14,157,653,974.

What is ANGO's forecast return on assets (ROA) for 2022-2024?

(NASDAQ: ANGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 6.62%.

What is ANGO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ANGO price target, the average ANGO price target is $34.50, with the highest ANGO stock price forecast at $37.00 and the lowest ANGO stock price forecast at $32.00.

On average, Wall Street analysts predict that Angiodynamics's share price could stay at $34.50 by Oct 15, 2022. The average Angiodynamics stock price prediction forecasts a potential downside of N/A from the current ANGO share price of $25.49.

What is ANGO's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: ANGO) Angiodynamics's current Earnings Per Share (EPS) is -$0.88. On average, analysts forecast that ANGO's EPS will be $0.01 for 2022, with the lowest EPS forecast at $0.01, and the highest EPS forecast at $0.02. In 2023, ANGO's EPS is forecast to hit $0.17 (min: $0.13, max: $0.22).

What is ANGO's forecast return on equity (ROE) for 2022-2024?

(NASDAQ: ANGO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.